Research ArticleBasic Science Investigation
Considerations in the Selection of Radiopharmaceuticals for Palliation of Bone Pain from Metastatic Osseous Lesions
Lionel G. Bouchet, Wesley E. Bolch, S. Murty Goddu, Roger W. Howell and Dandamudi V. Rao
Journal of Nuclear Medicine April 2000, 41 (4) 682-687;
Lionel G. Bouchet
Wesley E. Bolch
S. Murty Goddu
Roger W. Howell


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Considerations in the Selection of Radiopharmaceuticals for Palliation of Bone Pain from Metastatic Osseous Lesions
Lionel G. Bouchet, Wesley E. Bolch, S. Murty Goddu, Roger W. Howell, Dandamudi V. Rao
Journal of Nuclear Medicine Apr 2000, 41 (4) 682-687;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
- Targeting of Osseous Sites with {alpha}-Emitting 223Ra: Comparison with the {beta}-Emitter 89Sr in Mice
- Significant Antitumor Effect from Bone-seeking, {alpha}-Particle-emitting 223Ra Demonstrated in an Experimental Skeletal Metastases Model
- Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
- Marrow-Sparing Effects of 117mSn(4+)Diethylenetriaminepentaacetic Acid for Radionuclide Therapy of Bone Cancer